Follow along on Instagram ( @weightwatchers ), and TikTok ( @weightwatchers ), for more details
The MHRA has not approved any GLP-1 receptor agonist for use below the labelled doses, and this approach falls outside current prescribing guidelines
Ozempic /Wegovy and pancreatitis: Who should use extra caution or avoid GLP-1s
Kathryn Horton, a board-certified internal medicine physician, stated it directly: "Tirzepatide is a synthetic peptide that is rapidly degraded by digestive enzymes within the gastrointestinal tract." The larger molecular size and chemical modifications that enable dual-receptor agonism "currently pose significant challenges for the development of an effective oral formulation." For sublingual delivery specifically, the absorption story is slightly different but still problematic
York B, Reineke EL, Sagen JV, Nikolai BC, Zhou S, Louet JF, Chopra AR, Chen X, Reed G, Noebels J, Adesina AM, Yu H, Wong LJ, Tsimelzon A, Hilsenbeck S, Stevens RD, Wenner BR, Ilkayeva O, Xu J, Newgard CB, OMalley BW